25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VITR (Vitrolife) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vitrolife together

I guess you are interested in Vitrolife AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Vitrolife’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Vitrolife’s Price Targets

I'm going to help you getting a better view of Vitrolife AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.

1. Quick Overview

1.1. Quick analysis of Vitrolife (30 sec.)










1.2. What can you expect buying and holding a share of Vitrolife? (30 sec.)

How much money do you get?

How much money do you get?
kr0.11
When do you have the money?
1 year
How often do you get paid?
65.0%

What is your share worth?

Current worth
kr96.92
Expected worth in 1 year
kr96.13
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
kr0.21
Return On Investment
0.1%

For what price can you sell your share?

Current Price per Share
kr143.20
Expected price per share
kr122.21 - kr148.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vitrolife (5 min.)




Live pricePrice per Share (EOD)
kr143.20
Intrinsic Value Per Share
kr26.33 - kr50.88
Total Value Per Share
kr123.24 - kr147.80

2.2. Growth of Vitrolife (5 min.)




Is Vitrolife growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3b$1.6b-$212.6m-15.2%

How much money is Vitrolife making?

Current yearPrevious yearGrowGrow %
Making money$13.1m-$101.1m$114.3m870.3%
Net Profit Margin13.7%-105.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Vitrolife (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#28 / 298

Most Revenue
#70 / 298

Most Profit
#50 / 298
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vitrolife?

Welcome investor! Vitrolife's management wants to use your money to grow the business. In return you get a share of Vitrolife.

First you should know what it really means to hold a share of Vitrolife. And how you can make/lose money.

Speculation

The Price per Share of Vitrolife is kr143.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vitrolife.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vitrolife, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr96.92. Based on the TTM, the Book Value Change Per Share is kr-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is kr-6.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.25 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vitrolife.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.080.1%0.100.1%-0.75-0.5%-0.19-0.1%-0.09-0.1%-0.020.0%
Usd Book Value Change Per Share-0.39-0.3%-0.020.0%-0.74-0.5%-0.16-0.1%0.440.3%0.240.2%
Usd Dividend Per Share0.000.0%0.030.0%0.040.0%0.050.0%0.050.0%0.040.0%
Usd Total Gains Per Share-0.39-0.3%0.010.0%-0.69-0.5%-0.11-0.1%0.480.3%0.280.2%
Usd Price Per Share17.01-21.26-19.84-20.69-26.21-30.24-
Price to Earnings Ratio54.59-55.73-41.33-54.78-125.03-153.14-
Price-to-Total Gains Ratio-43.49--5,614.61--16.38--1,856.36--1,081.21--301.26-
Price to Book Ratio1.66-2.06-1.72-1.80-6.25-22.95-
Price-to-Total Gains Ratio-43.49--5,614.61--16.38--1,856.36--1,081.21--301.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.1076
Number of shares66
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.05
Usd Book Value Change Per Share-0.020.44
Usd Total Gains Per Share0.010.48
Gains per Quarter (66 shares)0.3731.76
Gains per Year (66 shares)1.49127.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17-5-912115117
214-11-824230244
321-16-736345371
428-22-648461498
535-27-559576625
642-33-471691752
749-38-383806879
856-44-2959211006
962-49-110710361133
1069-54011911521260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%83.02.00.097.6%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%33.07.00.082.5%69.016.00.081.2%
Dividend per Share1.00.03.025.0%7.00.05.058.3%14.00.06.070.0%26.00.014.065.0%36.00.049.042.4%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%15.05.00.075.0%34.06.00.085.0%72.013.00.084.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vitrolife AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.706-0.196-95%-6.981+88%-1.486-60%4.135-190%2.286-262%
Book Value Per Share--96.91697.788-1%112.712-14%110.863-13%83.809+16%46.502+108%
Current Ratio--3.7673.253+16%3.243+16%2.930+29%4.805-22%4.667-19%
Debt To Asset Ratio--0.2110.218-3%0.200+5%0.202+4%0.179+18%0.173+22%
Debt To Equity Ratio--0.2670.279-4%0.251+6%0.254+5%0.221+21%0.212+26%
Dividend Per Share---0.249-100%0.425-100%0.429-100%0.427-100%0.339-100%
Enterprise Value--19383057689.60024592429513.600-21%22529173679.200-14%23589171028.000-18%31903092932.880-39%37999922188.928-49%
Eps--0.7380.919-20%-7.080+1059%-1.800+344%-0.848+215%-0.170+123%
Ev To Ebitda Ratio--18.92927.546-31%14.301+32%21.234-11%50.198-62%89.331-79%
Ev To Sales Ratio--5.7556.832-16%6.433-11%6.780-15%15.320-62%29.878-81%
Free Cash Flow Per Share--0.5091.280-60%1.262-60%1.249-59%1.011-50%0.783-35%
Free Cash Flow To Equity Per Share--0.2440.871-72%0.709-66%0.560-56%2.680-91%1.525-84%
Gross Profit Margin---0.830-0.568-32%-0.101-88%-0.420-49%-0.408-51%-0.045-95%
Intrinsic Value_10Y_max--50.882----------
Intrinsic Value_10Y_min--26.328----------
Intrinsic Value_1Y_max--5.019----------
Intrinsic Value_1Y_min--3.069----------
Intrinsic Value_3Y_max--15.141----------
Intrinsic Value_3Y_min--8.903----------
Intrinsic Value_5Y_max--25.336----------
Intrinsic Value_5Y_min--14.343----------
Market Cap19396011545.600-13%21834057689.60027303179513.600-20%25467423679.200-14%26570337694.667-18%33653253382.880-35%38823864163.928-44%
Net Profit Margin--0.1190.137-14%-1.056+989%-0.265+323%-0.080+167%0.086+38%
Operating Margin--0.1780.152+17%-0.983+652%-0.209+217%-0.019+111%0.143+25%
Operating Ratio--0.8210.783+5%0.794+3%0.793+4%0.771+6%0.727+13%
Pb Ratio1.478-13%1.6632.059-19%1.719-3%1.803-8%6.249-73%22.951-93%
Pe Ratio48.490-13%54.58555.725-2%41.325+32%54.7830%125.026-56%153.139-64%
Price Per Share143.200-13%161.200201.475-20%188.025-14%196.133-18%248.440-35%286.625-44%
Price To Free Cash Flow Ratio70.275-13%79.10947.589+66%38.455+106%42.680+85%36.895+114%151.435-48%
Price To Total Gains Ratio-38.635+11%-43.492-5614.606+12810%-16.379-62%-1856.359+4168%-1081.207+2386%-301.259+593%
Quick Ratio--2.9752.561+16%2.378+25%2.182+36%3.957-25%3.680-19%
Return On Assets--0.0060.007-18%-0.059+1087%-0.016+360%0.000+1548%0.023-74%
Return On Equity--0.0080.009-19%-0.077+1107%-0.020+367%-0.001+113%0.027-72%
Total Gains Per Share---3.7060.054-7025%-6.556+77%-1.056-71%4.561-181%2.625-241%
Usd Book Value--1384898500.0001397980500.000-1%1610615750.000-14%1584407791.667-13%1197721001.350+16%664565528.788+108%
Usd Book Value Change Per Share---0.391-0.021-95%-0.736+88%-0.157-60%0.436-190%0.241-262%
Usd Book Value Per Share--10.22510.317-1%11.891-14%11.696-13%8.842+16%4.906+108%
Usd Dividend Per Share---0.026-100%0.045-100%0.045-100%0.045-100%0.036-100%
Usd Enterprise Value--2044912586.2532594501313.685-21%2376827823.156-14%2488657543.454-18%3365776304.419-39%4008991790.932-49%
Usd Eps--0.0780.097-20%-0.747+1059%-0.190+344%-0.089+215%-0.018+123%
Usd Free Cash Flow--7279500.00018304250.000-60%18040500.000-60%17855875.000-59%14442063.800-50%11196248.163-35%
Usd Free Cash Flow Per Share--0.0540.135-60%0.133-60%0.132-59%0.107-50%0.083-35%
Usd Free Cash Flow To Equity Per Share--0.0260.092-72%0.075-66%0.059-56%0.283-91%0.161-84%
Usd Market Cap2046279218.061-13%2303493086.2532880485438.685-20%2686813198.156-14%2803170626.787-18%3550418231.894-35%4095917669.294-44%
Usd Price Per Share15.108-13%17.00721.256-20%19.837-14%20.692-18%26.210-35%30.239-44%
Usd Profit--10550000.00013134750.000-20%-101174500.000+1059%-25724416.667+344%-12113346.475+215%-2432262.938+123%
Usd Revenue--88831000.00095187375.000-7%92259750.000-4%91811375.000-3%72729088.875+22%50679966.038+75%
Usd Total Gains Per Share---0.3910.006-7025%-0.692+77%-0.111-71%0.481-181%0.277-241%
 EOD+5 -3MRQTTM+9 -31YOY+16 -243Y+13 -275Y+15 -2510Y+14 -26

3.3 Fundamental Score

Let's check the fundamental score of Vitrolife AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1548.490
Price to Book Ratio (EOD)Between0-11.478
Net Profit Margin (MRQ)Greater than00.119
Operating Margin (MRQ)Greater than00.178
Quick Ratio (MRQ)Greater than12.975
Current Ratio (MRQ)Greater than13.767
Debt to Asset Ratio (MRQ)Less than10.211
Debt to Equity Ratio (MRQ)Less than10.267
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.457
Ma 20Greater thanMa 50144.245
Ma 50Greater thanMa 100150.352
Ma 100Greater thanMa 200165.112
OpenGreater thanClose141.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2025-07-03 08:43:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Vitrolife earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • A Net Profit Margin of 11.9%Β means thatΒ kr0.12 for each kr1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vitrolife AB:

  • The MRQ is 11.9%. The company is making a huge profit. +2
  • The TTM is 13.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.9%TTM13.7%-1.9%
TTM13.7%YOY-105.6%+119.4%
TTM13.7%5Y-8.0%+21.8%
5Y-8.0%10Y8.6%-16.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9%-7.7%+19.6%
TTM13.7%-10.2%+23.9%
YOY-105.6%-10.9%-94.7%
3Y-26.5%-12.8%-13.7%
5Y-8.0%-10.3%+2.3%
10Y8.6%-9.3%+17.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Vitrolife is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • 0.6% Return on Assets means thatΒ Vitrolife generatedΒ kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vitrolife AB:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.7%-0.1%
TTM0.7%YOY-5.9%+6.7%
TTM0.7%5Y0.0%+0.7%
5Y0.0%10Y2.3%-2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-2.1%+2.7%
TTM0.7%-2.4%+3.1%
YOY-5.9%-3.1%-2.8%
3Y-1.6%-2.6%+1.0%
5Y0.0%-2.6%+2.6%
10Y2.3%-2.4%+4.7%
4.3.1.3. Return on Equity

Shows how efficient Vitrolife is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • 0.8% Return on Equity means Vitrolife generated kr0.01Β for eachΒ kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vitrolife AB:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.9%-0.2%
TTM0.9%YOY-7.7%+8.6%
TTM0.9%5Y-0.1%+1.0%
5Y-0.1%10Y2.7%-2.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-1.9%+2.7%
TTM0.9%-2.6%+3.5%
YOY-7.7%-2.6%-5.1%
3Y-2.0%-3.7%+1.7%
5Y-0.1%-4.2%+4.1%
10Y2.7%-5.8%+8.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vitrolife AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Vitrolife is operatingΒ .

  • Measures how much profit Vitrolife makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • An Operating Margin of 17.8%Β means the company generated kr0.18 Β for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vitrolife AB:

  • The MRQ is 17.8%. The company is operating efficient. +1
  • The TTM is 15.2%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.8%TTM15.2%+2.6%
TTM15.2%YOY-98.3%+113.6%
TTM15.2%5Y-1.9%+17.1%
5Y-1.9%10Y14.3%-16.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ17.8%-12.1%+29.9%
TTM15.2%-13.6%+28.8%
YOY-98.3%-9.9%-88.4%
3Y-20.9%-9.6%-11.3%
5Y-1.9%-9.5%+7.6%
10Y14.3%-9.4%+23.7%
4.3.2.2. Operating Ratio

Measures how efficient Vitrolife is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 0.82 means that the operating costs are kr0.82 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vitrolife AB:

  • The MRQ is 0.821. The company is less efficient in keeping operating costs low.
  • The TTM is 0.783. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.821TTM0.783+0.038
TTM0.783YOY0.794-0.011
TTM0.7835Y0.771+0.012
5Y0.77110Y0.727+0.044
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8211.395-0.574
TTM0.7831.367-0.584
YOY0.7941.275-0.481
3Y0.7931.337-0.544
5Y0.7711.349-0.578
10Y0.7271.321-0.594
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vitrolife AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vitrolife is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 3.77Β means the company has kr3.77 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vitrolife AB:

  • The MRQ is 3.767. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.253. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.767TTM3.253+0.514
TTM3.253YOY3.243+0.010
TTM3.2535Y4.805-1.552
5Y4.80510Y4.667+0.137
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7672.516+1.251
TTM3.2532.611+0.642
YOY3.2432.651+0.592
3Y2.9302.949-0.019
5Y4.8053.539+1.266
10Y4.6673.302+1.365
4.4.3.2. Quick Ratio

Measures if Vitrolife is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • A Quick Ratio of 2.98Β means the company can pay off kr2.98 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vitrolife AB:

  • The MRQ is 2.975. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.561. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.975TTM2.561+0.414
TTM2.561YOY2.378+0.184
TTM2.5615Y3.957-1.396
5Y3.95710Y3.680+0.277
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9751.107+1.868
TTM2.5611.412+1.149
YOY2.3781.652+0.726
3Y2.1821.816+0.366
5Y3.9572.145+1.812
10Y3.6802.350+1.330
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vitrolife AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of VitrolifeΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Vitrolife to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.21Β means that Vitrolife assets areΒ financed with 21.1% credit (debt) and the remaining percentage (100% - 21.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Vitrolife AB:

  • The MRQ is 0.211. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.218. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.211TTM0.218-0.008
TTM0.218YOY0.200+0.018
TTM0.2185Y0.179+0.040
5Y0.17910Y0.173+0.006
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2110.400-0.189
TTM0.2180.410-0.192
YOY0.2000.391-0.191
3Y0.2020.388-0.186
5Y0.1790.414-0.235
10Y0.1730.455-0.282
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Vitrolife is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 26.7% means that company has kr0.27 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vitrolife AB:

  • The MRQ is 0.267. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.279. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.279-0.012
TTM0.279YOY0.251+0.029
TTM0.2795Y0.221+0.059
5Y0.22110Y0.212+0.009
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2670.554-0.287
TTM0.2790.636-0.357
YOY0.2510.589-0.338
3Y0.2540.631-0.377
5Y0.2210.647-0.426
10Y0.2120.754-0.542
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every kr1 in earnings Vitrolife generates.

  • Above 15 is considered overpriced butΒ always compareΒ Vitrolife to theΒ Medical Devices industry mean.
  • A PE ratio of 54.59 means the investor is paying kr54.59Β for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vitrolife AB:

  • The EOD is 48.490. Based on the earnings, the company is overpriced. -1
  • The MRQ is 54.585. Based on the earnings, the company is expensive. -2
  • The TTM is 55.725. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD48.490MRQ54.585-6.095
MRQ54.585TTM55.725-1.140
TTM55.725YOY41.325+14.400
TTM55.7255Y125.026-69.301
5Y125.02610Y153.139-28.113
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD48.490-1.153+49.643
MRQ54.585-1.449+56.034
TTM55.725-1.183+56.908
YOY41.325-1.829+43.154
3Y54.783-1.328+56.111
5Y125.026-1.482+126.508
10Y153.139-1.435+154.574
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vitrolife AB:

  • The EOD is 70.275. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 79.109. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 47.589. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD70.275MRQ79.109-8.834
MRQ79.109TTM47.589+31.520
TTM47.589YOY38.455+9.134
TTM47.5895Y36.895+10.694
5Y36.89510Y151.435-114.540
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD70.275-2.438+72.713
MRQ79.109-3.182+82.291
TTM47.589-1.554+49.143
YOY38.455-3.394+41.849
3Y42.680-2.971+45.651
5Y36.895-2.902+39.797
10Y151.435-3.337+154.772
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Vitrolife is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 1.66 means the investor is paying kr1.66Β for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vitrolife AB:

  • The EOD is 1.478. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.663. Based on the equity, the company is underpriced. +1
  • The TTM is 2.059. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.478MRQ1.663-0.186
MRQ1.663TTM2.059-0.396
TTM2.059YOY1.719+0.340
TTM2.0595Y6.249-4.190
5Y6.24910Y22.951-16.702
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4781.943-0.465
MRQ1.6631.993-0.330
TTM2.0592.254-0.195
YOY1.7192.669-0.950
3Y1.8032.718-0.915
5Y6.2493.855+2.394
10Y22.9514.251+18.700
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets16,632,000
Total Liabilities3,505,000
Total Stockholder Equity13,125,000
 As reported
Total Liabilities 3,505,000
Total Stockholder Equity+ 13,125,000
Total Assets = 16,632,000

Assets

Total Assets16,632,000
Total Current Assets2,279,000
Long-term Assets14,353,000
Total Current Assets
Cash And Cash Equivalents 1,054,000
Net Receivables 746,000
Inventory 413,000
Other Current Assets 66,000
Total Current Assets  (as reported)2,279,000
Total Current Assets  (calculated)2,279,000
+/-0
Long-term Assets
Property Plant Equipment 413,000
Goodwill 9,701,000
Intangible Assets 4,050,000
Long-term Assets Other 53,000
Long-term Assets  (as reported)14,353,000
Long-term Assets  (calculated)14,217,000
+/- 136,000

Liabilities & Shareholders' Equity

Total Current Liabilities605,000
Long-term Liabilities2,900,000
Total Stockholder Equity13,125,000
Total Current Liabilities
Short-term Debt 151,000
Short Long Term Debt 108,000
Accounts payable 149,000
Other Current Liabilities 271,000
Total Current Liabilities  (as reported)605,000
Total Current Liabilities  (calculated)679,000
+/- 74,000
Long-term Liabilities
Long term Debt 1,710,000
Capital Lease Obligations 133,000
Long-term Liabilities Other 60,000
Long-term Liabilities  (as reported)2,900,000
Long-term Liabilities  (calculated)1,903,000
+/- 997,000
Total Stockholder Equity
Common Stock28,000
Retained Earnings -1,504,000
Other Stockholders Equity 14,601,000
Total Stockholder Equity (as reported)13,125,000
Total Stockholder Equity (calculated)13,125,000
+/-0
Other
Capital Stock28,000
Cash and Short Term Investments 1,054,000
Common Stock Shares Outstanding 135,423
Liabilities and Stockholders Equity 16,632,000
Net Debt 897,000
Net Invested Capital 14,943,000
Net Working Capital 1,674,000
Short Long Term Debt Total 1,951,000



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-06-30
> Total Assets 
116,790
312,222
328,042
292,784
188,515
158,754
183,995
193,055
193,661
192,714
185,538
193,369
205,990
206,727
211,370
280,024
276,381
281,880
271,034
285,361
291,012
295,811
299,460
306,758
317,817
323,243
342,662
351,868
342,141
339,523
359,315
374,309
389,393
388,251
429,388
436,471
442,136
463,004
466,780
473,881
501,471
495,293
462,198
465,841
479,565
467,236
487,808
497,442
505,265
554,346
972,482
960,446
957,279
993,135
1,059,243
1,107,151
1,128,830
1,189,371
1,250,491
1,286,096
1,302,928
1,317,216
1,422,424
1,550,134
1,566,360
1,619,292
1,697,467
1,880,172
1,952,673
2,092,341
2,138,687
2,247,569
2,203,185
2,255,316
2,305,089
2,497,494
2,513,722
6,140,833
19,428,796
19,535,000
19,907,000
20,206,000
20,551,000
20,762,000
21,648,000
21,180,000
16,391,000
16,873,000
16,852,000
16,884,000
17,446,000
16,632,000
16,632,00017,446,00016,884,00016,852,00016,873,00016,391,00021,180,00021,648,00020,762,00020,551,00020,206,00019,907,00019,535,00019,428,7966,140,8332,513,7222,497,4942,305,0892,255,3162,203,1852,247,5692,138,6872,092,3411,952,6731,880,1721,697,4671,619,2921,566,3601,550,1341,422,4241,317,2161,302,9281,286,0961,250,4911,189,3711,128,8301,107,1511,059,243993,135957,279960,446972,482554,346505,265497,442487,808467,236479,565465,841462,198495,293501,471473,881466,780463,004442,136436,471429,388388,251389,393374,309359,315339,523342,141351,868342,662323,243317,817306,758299,460295,811291,012285,361271,034281,880276,381280,024211,370206,727205,990193,369185,538192,714193,661193,055183,995158,754188,515292,784328,042312,222116,790
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,818
0
115,751
118,378
131,563
137,267
133,610
144,556
153,436
164,696
242,131
249,369
142,816
155,863
161,969
161,664
187,325
203,255
213,122
260,255
308,782
301,490
314,634
354,566
414,454
466,823
340,605
397,477
476,519
532,647
562,887
604,247
709,905
757,817
777,613
849,720
850,576
956,480
918,350
1,069,634
1,150,224
1,237,464
1,239,973
1,310,340
1,414,442
1,593,101
1,623,547
5,252,743
1,406,601
1,409,000
1,328,000
1,408,000
1,572,000
1,653,000
1,816,000
1,825,000
1,914,000
2,048,000
1,998,000
2,110,000
2,357,000
2,279,000
2,279,0002,357,0002,110,0001,998,0002,048,0001,914,0001,825,0001,816,0001,653,0001,572,0001,408,0001,328,0001,409,0001,406,6015,252,7431,623,5471,593,1011,414,4421,310,3401,239,9731,237,4641,150,2241,069,634918,350956,480850,576849,720777,613757,817709,905604,247562,887532,647476,519397,477340,605466,823414,454354,566314,634301,490308,782260,255213,122203,255187,325161,664161,969155,863142,816249,369242,131164,696153,436144,556133,610137,267131,563118,378115,7510103,818000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,987
0
11,344
9,608
18,617
17,811
10,408
15,516
20,873
26,764
19,115
15,018
11,680
19,309
18,824
30,997
53,769
65,514
70,805
119,274
107,598
90,458
75,648
115,902
199,572
202,333
75,971
118,651
189,245
218,078
235,739
285,055
395,963
399,289
421,397
496,225
490,810
522,078
446,548
599,010
689,538
715,478
753,796
834,256
973,566
1,117,594
1,155,482
4,763,324
630,094
583,000
444,000
461,000
578,000
618,000
687,000
778,000
861,000
947,000
853,000
925,000
1,135,000
1,054,000
1,054,0001,135,000925,000853,000947,000861,000778,000687,000618,000578,000461,000444,000583,000630,0944,763,3241,155,4821,117,594973,566834,256753,796715,478689,538599,010446,548522,078490,810496,225421,397399,289395,963285,055235,739218,078189,245118,65175,971202,333199,572115,90275,64890,458107,598119,27470,80565,51453,76930,99718,82419,30911,68015,01819,11526,76420,87315,51610,40817,81118,6179,60811,344015,987000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
289
0
0
0
120
0
0
0
17
0
0
0
842
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000-10000000000084200017000120000289000000000000000000000000000000000000000000
       Net Receivables 
18,495
22,871
24,601
25,159
23,055
21,086
13,424
19,615
19,185
18,325
13,244
22,796
24,732
18,669
15,697
32,379
31,671
30,945
28,090
38,151
33,998
33,184
27,410
41,334
43,764
43,657
38,655
52,705
54,071
48,300
38,768
53,593
52,128
48,857
42,830
64,584
67,072
68,637
57,291
68,670
64,164
67,533
52,436
56,584
68,046
54,193
61,456
63,222
69,595
65,526
84,620
92,259
109,846
104,542
99,783
112,201
121,444
126,906
133,514
160,841
178,186
173,145
153,614
194,970
184,818
186,025
189,231
239,900
259,966
250,537
240,179
274,530
218,978
236,751
216,494
248,319
227,707
239,138
431,156
455,000
459,000
492,000
542,000
573,000
612,000
535,000
503,000
645,000
697,000
708,000
767,000
746,000
746,000767,000708,000697,000645,000503,000535,000612,000573,000542,000492,000459,000455,000431,156239,138227,707248,319216,494236,751218,978274,530240,179250,537259,966239,900189,231186,025184,818194,970153,614173,145178,186160,841133,514126,906121,444112,20199,783104,542109,84692,25984,62065,52669,59563,22261,45654,19368,04656,58452,43667,53364,16468,67057,29168,63767,07264,58442,83048,85752,12853,59338,76848,30054,07152,70538,65543,65743,76441,33427,41033,18433,99838,15128,09030,94531,67132,37915,69718,66924,73222,79613,24418,32519,18519,61513,42421,08623,05525,15924,60122,87118,495
       Other Current Assets 
0
0
2,399
0
1,466
0
1,534
0
0
0
3,046
0
0
0
3,092
0
0
0
4,199
0
0
0
3,215
0
0
0
6,098
0
0
532
45,984
4,788
56,573
53,941
56,336
67,021
67,383
68,637
66,854
69,438
159,855
171,694
68,727
17,520
10,804
13,292
12,064
12,971
11,971
12,332
24,871
20,460
23,472
22,551
11,973
45,969
19,235
17,086
15,433
15,177
17,234
14,302
15,150
23,334
23,392
19,779
17,578
25,385
28,916
21,813
18,545
29,258
46,157
46,799
20,355
22,981
28,805
24,541
32,457
76,000
67,000
113,000
135,000
122,000
137,000
115,000
137,000
133,000
167,000
782,000
33,000
66,000
66,00033,000782,000167,000133,000137,000115,000137,000122,000135,000113,00067,00076,00032,45724,54128,80522,98120,35546,79946,15729,25818,54521,81328,91625,38517,57819,77923,39223,33415,15014,30217,23415,17715,43317,08619,23545,96911,97322,55123,47220,46024,87112,33211,97112,97112,06413,29210,80417,52068,727171,694159,85569,43866,85468,63767,38367,02156,33653,94156,5734,78845,984532006,0980003,2150004,1990003,0920003,0460001,53401,46602,39900
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,497
0
273,642
269,873
297,825
299,204
308,526
318,448
313,344
309,185
259,340
245,924
319,382
309,978
317,596
305,572
300,483
294,187
292,143
294,091
663,700
658,956
642,645
638,569
644,789
640,328
788,225
791,894
773,972
753,449
740,041
712,969
712,519
792,317
788,747
769,572
846,891
923,692
1,034,323
1,022,707
988,463
1,010,105
963,212
944,976
890,648
904,393
890,177
888,090
18,022,195
18,126,000
18,579,000
18,798,000
18,978,000
19,109,000
19,832,000
19,355,000
14,477,000
14,825,000
14,854,000
14,774,000
15,089,000
14,353,000
14,353,00015,089,00014,774,00014,854,00014,825,00014,477,00019,355,00019,832,00019,109,00018,978,00018,798,00018,579,00018,126,00018,022,195888,090890,177904,393890,648944,976963,2121,010,105988,4631,022,7071,034,323923,692846,891769,572788,747792,317712,519712,969740,041753,449773,972791,894788,225640,328644,789638,569642,645658,956663,700294,091292,143294,187300,483305,572317,596309,978319,382245,924259,340309,185313,344318,448308,526299,204297,825269,873273,6420255,497000000000000000000000000000000
       Property Plant Equipment 
36,185
67,666
106,370
136,887
94,155
88,979
77,385
81,716
84,425
86,828
83,656
89,721
97,276
88,527
88,802
88,860
85,328
83,677
81,736
82,612
81,333
77,444
76,639
72,137
76,114
86,610
94,802
103,389
98,763
92,990
93,038
91,531
94,142
86,598
91,316
95,209
95,304
97,519
95,444
92,520
101,019
95,957
94,445
93,873
93,005
87,172
85,956
83,878
84,214
85,366
92,322
95,776
91,697
90,271
89,641
87,681
90,533
90,536
93,655
91,517
89,672
84,895
84,432
86,427
91,246
90,440
94,126
174,598
176,168
180,580
173,359
175,747
164,025
154,079
142,113
146,759
160,441
159,451
332,974
347,000
359,000
342,000
318,000
307,000
349,000
353,000
349,000
368,000
379,000
391,000
428,000
413,000
413,000428,000391,000379,000368,000349,000353,000349,000307,000318,000342,000359,000347,000332,974159,451160,441146,759142,113154,079164,025175,747173,359180,580176,168174,59894,12690,44091,24686,42784,43284,89589,67291,51793,65590,53690,53387,68189,64190,27191,69795,77692,32285,36684,21483,87885,95687,17293,00593,87394,44595,957101,01992,52095,44497,51995,30495,20991,31686,59894,14291,53193,03892,99098,763103,38994,80286,61076,11472,13776,63977,44481,33382,61281,73683,67785,32888,86088,80288,52797,27689,72183,65686,82884,42581,71677,38588,97994,155136,887106,37067,66636,185
       Goodwill 
0
0
22,001
0
4,741
0
4,011
0
3,646
3,464
3,282
4,011
4,011
4,011
4,011
83,265
83,265
83,265
83,265
83,265
83,265
83,265
83,265
87,542
87,542
88,250
88,250
89,294
89,294
89,294
97,301
97,301
97,301
97,301
120,289
118,221
118,355
120,736
120,771
119,584
120,952
114,995
182,114
175,586
182,670
180,105
183,275
180,969
183,789
185,400
364,545
364,835
358,394
364,252
350,474
351,793
394,052
402,128
403,216
402,393
404,806
399,718
408,937
422,562
424,994
421,583
421,610
427,790
430,915
435,619
425,841
442,311
422,241
421,413
403,239
411,717
409,736
411,441
12,994,620
13,111,000
13,461,000
13,696,000
13,874,000
14,025,000
14,552,000
14,244,000
9,591,000
9,867,000
9,898,000
9,857,000
10,121,000
9,701,000
9,701,00010,121,0009,857,0009,898,0009,867,0009,591,00014,244,00014,552,00014,025,00013,874,00013,696,00013,461,00013,111,00012,994,620411,441409,736411,717403,239421,413422,241442,311425,841435,619430,915427,790421,610421,583424,994422,562408,937399,718404,806402,393403,216402,128394,052351,793350,474364,252358,394364,835364,545185,400183,789180,969183,275180,105182,670175,586182,114114,995120,952119,584120,771120,736118,355118,221120,28997,30197,30197,30197,30189,29489,29489,29488,25088,25087,54287,54283,26583,26583,26583,26583,26583,26583,26583,2654,0114,0114,0114,0113,2823,4643,64604,01104,741022,00100
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
23,602
26,118
30,774
32,414
32,674
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000032,67432,41430,77426,11823,60218,38713,61112,7069,1689,1009,1628,9178,9480000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
25,712
25,527
26,010
30,278
7,841
12,238
6,480
12,160
3,646
3,464
6,563
13,777
15,190
23,429
7,805
110,966
110,838
110,020
92,243
108,210
108,266
107,712
91,569
110,797
111,107
113,242
96,924
117,978
117,734
119,721
34,506
136,803
48,163
54,417
65,323
68,358
76,681
204,005
83,666
205,330
144,634
21,316
33,892
32,376
40,760
37,058
22,982
19,176
18,368
17,136
196,846
187,339
181,957
175,556
165,044
161,926
266,288
261,432
245,871
231,768
221,415
204,929
198,801
264,339
254,046
238,500
306,387
293,777
382,119
371,280
352,417
352,931
329,079
319,669
299,480
295,615
281,676
268,808
4,552,903
4,536,000
4,609,000
4,635,000
4,648,000
4,629,000
4,755,000
4,573,000
4,312,000
4,403,000
4,384,000
4,318,000
4,342,000
4,050,000
4,050,0004,342,0004,318,0004,384,0004,403,0004,312,0004,573,0004,755,0004,629,0004,648,0004,635,0004,609,0004,536,0004,552,903268,808281,676295,615299,480319,669329,079352,931352,417371,280382,119293,777306,387238,500254,046264,339198,801204,929221,415231,768245,871261,432266,288161,926165,044175,556181,957187,339196,84617,13618,36819,17622,98237,05840,76032,37633,89221,316144,634205,33083,666204,00576,68168,35865,32354,41748,163136,80334,506119,721117,734117,97896,924113,242111,107110,79791,569107,712108,266108,21092,243110,020110,838110,9667,80523,42915,19013,7776,5633,4643,64612,1606,48012,2387,84130,27826,01025,52725,712
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,036
31,557
2,565
17,416
18,186
16,924
2,318
11,335
13,687
13,656
2
3,225
2,322
2,474
2
5,548
11,544
12,378
-33,302
22,012
21,194
16,980
9,666
9,371
8,106
8,122
8,948
8,917
9,162
9,100
9,168
12,706
13,611
18,387
-1
26,118
30,774
32,414
-1
35,024
43,273
44,814
1
40,184
27,202
31,267
2
49,000
50,000
36,000
36,000
1,000
1,000
49,000
2,000
4,403,000
-1,000
0
54,000
53,000
53,00054,0000-1,0004,403,0002,00049,0001,0001,00036,00036,00050,00049,000231,26727,20240,184144,81443,27335,024-132,41430,77426,118-118,38713,61112,7069,1689,1009,1628,9178,9488,1228,1069,3719,66616,98021,19422,012-33,30212,37811,5445,54822,4742,3223,225213,65613,68711,3352,31816,92418,18617,4162,56531,55734,03600000000000000000000000000000000
> Total Liabilities 
29,940
52,648
86,301
70,961
76,070
60,111
40,560
41,649
39,528
36,823
34,964
32,574
36,917
34,428
34,920
63,728
60,232
59,986
50,395
52,720
49,903
50,368
46,076
49,692
54,173
50,258
50,274
47,672
44,237
40,872
47,246
48,699
57,129
60,475
103,055
110,932
119,260
122,762
122,877
123,823
144,491
523,516
183,216
179,948
186,867
162,468
165,208
155,332
162,006
170,096
269,911
218,618
220,079
192,178
214,271
222,555
233,056
233,124
230,107
209,265
213,468
176,507
193,775
218,738
221,269
208,358
201,255
282,941
349,328
364,709
341,059
320,958
315,638
294,616
288,075
333,539
362,780
364,747
4,087,926
3,993,000
3,917,000
3,804,000
3,811,000
3,747,000
3,969,000
3,749,000
3,668,000
3,640,000
3,755,000
3,745,000
3,805,000
3,505,000
3,505,0003,805,0003,745,0003,755,0003,640,0003,668,0003,749,0003,969,0003,747,0003,811,0003,804,0003,917,0003,993,0004,087,926364,747362,780333,539288,075294,616315,638320,958341,059364,709349,328282,941201,255208,358221,269218,738193,775176,507213,468209,265230,107233,124233,056222,555214,271192,178220,079218,618269,911170,096162,006155,332165,208162,468186,867179,948183,216523,516144,491123,823122,877122,762119,260110,932103,05560,47557,12948,69947,24640,87244,23747,67250,27450,25854,17349,69246,07650,36849,90352,72050,39559,98660,23263,72834,92034,42836,91732,57434,96436,82339,52841,64940,56060,11176,07070,96186,30152,64829,940
   > Total Current Liabilities 
29,940
32,648
44,299
40,551
49,176
38,531
20,994
21,591
19,594
17,363
18,873
15,869
20,228
17,881
19,368
24,591
22,823
23,209
28,574
31,880
31,351
33,396
31,340
36,493
50,334
45,745
46,952
43,389
41,482
39,084
40,053
41,826
51,302
55,451
71,284
76,232
88,083
91,182
61,332
71,060
90,539
474,286
80,168
92,663
111,730
95,280
99,724
100,565
106,353
118,278
159,831
135,093
143,723
126,426
131,396
139,800
124,881
128,385
159,318
141,295
147,575
116,316
134,895
130,401
132,617
120,702
152,275
163,862
191,770
223,092
202,352
180,523
181,878
169,054
177,014
220,844
240,548
245,494
954,326
918,000
748,000
670,000
621,000
596,000
651,000
596,000
557,000
556,000
669,000
724,000
705,000
605,000
605,000705,000724,000669,000556,000557,000596,000651,000596,000621,000670,000748,000918,000954,326245,494240,548220,844177,014169,054181,878180,523202,352223,092191,770163,862152,275120,702132,617130,401134,895116,316147,575141,295159,318128,385124,881139,800131,396126,426143,723135,093159,831118,278106,353100,56599,72495,280111,73092,66380,168474,28690,53971,06061,33291,18288,08376,23271,28455,45151,30241,82640,05339,08441,48243,38946,95245,74550,33436,49331,34033,39631,35131,88028,57423,20922,82324,59119,36817,88120,22815,86918,87317,36319,59421,59120,99438,53149,17640,55144,29932,64829,940
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,981
0
10,389
13,012
20,406
29,393
37,947
40,589
5,424
10,653
12,413
399,034
16,825
71,848
94,942
83,250
-39,421
16,820
17,166
16,385
-76,489
20,060
107,313
12,235
11,876
12,002
12,319
12,601
-36,796
34,207
31,518
79
-80,555
85
0
0
0
10,683
13,131
14,175
-155,057
15,409
15,147
14,440
-21,757
13,302
15,948
15,675
456,000
474,000
305,000
199,000
182,000
148,000
149,000
145,000
180,000
119,000
148,000
152,000
160,000
151,000
151,000160,000152,000148,000119,000180,000145,000149,000148,000182,000199,000305,000474,000456,00015,67515,94813,302-21,75714,44015,14715,409-155,05714,17513,13110,68300085-80,5557931,51834,207-36,79612,60112,31912,00211,87612,235107,31320,060-76,48916,38517,16616,820-39,42183,25094,94271,84816,825399,03412,41310,6535,42440,58937,94729,39320,40613,01210,38902,981000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,856
34,653
31,950
79
81
85
0
0
0
29,033
33,635
31,072
0
0
0
0
0
0
0
0
428,610
442,000
273,000
169,000
153,000
119,000
113,000
109,000
114,000
84,000
114,000
113,000
115,000
108,000
108,000115,000113,000114,00084,000114,000109,000113,000119,000153,000169,000273,000442,000428,6100000000031,07233,63529,03300085817931,95034,65337,8560000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
11,523
0
9,615
0
6,399
0
0
6,563
8,680
5,846
8,635
6,855
7,263
8,931
6,167
8,023
9,170
10,989
9,521
12,372
9,505
10,963
16,817
14,207
23,531
14,544
11,523
13,075
14,697
15,149
16,274
19,642
26,643
19,286
17,380
18,206
19,865
23,743
21,258
18,464
17,444
20,815
16,788
12,030
15,596
17,567
11,106
19,444
22,282
20,436
20,415
17,668
21,749
22,785
21,806
23,272
24,286
24,609
24,274
27,793
30,598
24,876
28,195
26,483
32,085
40,039
36,088
40,517
29,314
30,934
38,850
23,848
25,922
47,601
46,901
45,079
173,000
179,000
187,000
201,000
181,000
174,000
224,000
163,000
171,000
164,000
167,000
190,000
203,000
149,000
149,000203,000190,000167,000164,000171,000163,000224,000174,000181,000201,000187,000179,000173,00045,07946,90147,60125,92223,84838,85030,93429,31440,51736,08840,03932,08526,48328,19524,87630,59827,79324,27424,60924,28623,27221,80622,78521,74917,66820,41520,43622,28219,44411,10617,56715,59612,03016,78820,81517,44418,46421,25823,74319,86518,20617,38019,28626,64319,64216,27415,14914,69713,07511,52314,54423,53114,20716,81710,9639,50512,3729,52110,9899,1708,0236,1678,9317,2636,8558,6355,8468,6806,563006,39909,615011,52300
       Other Current Liabilities 
0
0
17,265
0
33,211
0
13,200
0
0
9,405
7,948
7,650
9,003
8,447
9,461
11,016
12,012
10,542
12,851
14,338
15,277
14,471
15,396
19,091
21,658
20,679
20,204
26,628
27,742
22,376
2,744
23,696
24,639
22,797
24,235
27,553
32,756
31,487
32,649
36,664
48,999
46,408
36,044
55,022
77,723
67,724
-6,646
64,511
76,138
81,656
-28,800
75,533
88,070
46,415
-35,771
68,454
54,604
51,919
-14,485
72,205
70,137
69,254
-9,220
2,640
96,201
85,876
90,502
21,254
11,351
-9,607
-11,867
11,974
31,498
20,376
101,377
10,255
19,889
-2,468
298,837
38,000
215,000
216,000
185,000
240,000
11,000
-1,000
135,000
197,000
208,000
280,000
316,000
271,000
271,000316,000280,000208,000197,000135,000-1,00011,000240,000185,000216,000215,00038,000298,837-2,46819,88910,255101,37720,37631,49811,974-11,867-9,60711,35121,25490,50285,87696,2012,640-9,22069,25470,13772,205-14,48551,91954,60468,454-35,77146,41588,07075,533-28,80081,65676,13864,511-6,64667,72477,72355,02236,04446,40848,99936,66432,64931,48732,75627,55324,23522,79724,63923,6962,74422,37627,74226,62820,20420,67921,65819,09115,39614,47115,27714,33812,85110,54212,01211,0169,4618,4479,0037,6507,9489,4050013,200033,211017,26500
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,193
0
5,827
5,024
31,771
34,700
31,177
31,580
61,545
52,763
53,952
49,230
103,048
87,285
75,137
67,188
65,484
54,767
55,653
51,818
110,080
83,525
76,356
65,752
82,875
82,755
108,175
104,739
70,789
67,970
65,893
60,191
58,880
88,337
88,652
87,656
48,980
119,079
157,558
141,617
138,707
140,435
133,760
125,562
111,061
112,695
122,232
119,253
3,133,600
3,075,000
3,169,000
3,134,000
3,190,000
3,151,000
3,318,000
3,153,000
3,111,000
3,084,000
3,086,000
3,021,000
3,100,000
2,900,000
2,900,0003,100,0003,021,0003,086,0003,084,0003,111,0003,153,0003,318,0003,151,0003,190,0003,134,0003,169,0003,075,0003,133,600119,253122,232112,695111,061125,562133,760140,435138,707141,617157,558119,07948,98087,65688,65288,33758,88060,19165,89367,97070,789104,739108,17582,75582,87565,75276,35683,525110,08051,81855,65354,76765,48467,18875,13787,285103,04849,23053,95252,76361,54531,58031,17734,70031,7715,0245,82707,193000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,181
48,810
46,743
55,880
52,609
2,026,821
1,983,000
2,038,000
2,009,000
2,043,000
2,007,000
2,125,000
2,011,000
0
0
0
0
0
0
0000002,011,0002,125,0002,007,0002,043,0002,009,0002,038,0001,983,0002,026,82152,60955,88046,74348,81052,1810000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
543
543
0
0
0
0
0
0
0
0
1
0
0
0
2,489
0
0
0
2,285
0
0
0
0
0
850
850
33,735
24,465
27,277
36,590
29,192
22,917
23,872
24,144
23,791
6,303
5,529
5,205
5,191
10,188
9,140
8,395
9,043
9,012
10,302
7,214
7,311
37,120
88,652
87,656
48,980
52,887
91,376
77,280
77,494
81,148
77,869
73,381
62,251
65,952
66,352
66,644
1,106,779
1,092,000
1,131,000
1,125,000
1,147,000
1,144,000
0
0
0
0
0
0
0
0
000000001,144,0001,147,0001,125,0001,131,0001,092,0001,106,77966,64466,35265,95262,25173,38177,86981,14877,49477,28091,37652,88748,98087,65688,65237,1207,3117,21410,3029,0129,0438,3959,14010,1885,1915,2055,5296,30323,79124,14423,87222,91729,19236,59027,27724,46533,735850850000002,2850002,4890001000000005435430000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,999
0
0
0
51,772
0
0
0
41,905
0
0
0
36,524
0
0
0
34,111
0
0
0
58,436
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000058,43600034,11100036,52400041,90500051,77200066,9990000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
86,850
259,574
241,741
221,823
111,400
97,742
143,435
151,406
154,133
155,891
150,574
160,795
169,073
172,299
176,450
216,296
216,149
221,894
220,639
232,641
241,109
245,443
253,384
256,654
263,122
272,469
292,061
303,882
297,475
298,200
311,588
325,007
331,572
327,075
325,676
324,755
321,961
339,278
342,970
349,022
355,858
-29,362
277,791
284,610
291,205
303,198
320,956
340,299
341,694
382,631
700,914
739,970
735,133
798,764
843,151
882,486
893,818
954,117
1,018,055
1,074,054
1,087,045
1,138,129
1,225,857
1,327,995
1,341,974
1,407,781
1,492,914
1,593,568
1,600,108
1,724,250
1,794,023
1,922,499
1,883,653
1,956,346
2,012,570
2,158,713
2,146,647
5,771,466
15,322,175
15,529,000
15,977,000
16,386,000
16,736,000
17,013,000
17,677,000
17,430,000
12,722,000
13,231,000
13,096,000
13,137,000
13,639,000
13,125,000
13,125,00013,639,00013,137,00013,096,00013,231,00012,722,00017,430,00017,677,00017,013,00016,736,00016,386,00015,977,00015,529,00015,322,1755,771,4662,146,6472,158,7132,012,5701,956,3461,883,6531,922,4991,794,0231,724,2501,600,1081,593,5681,492,9141,407,7811,341,9741,327,9951,225,8571,138,1291,087,0451,074,0541,018,055954,117893,818882,486843,151798,764735,133739,970700,914382,631341,694340,299320,956303,198291,205284,610277,791-29,362355,858349,022342,970339,278321,961324,755325,676327,075331,572325,007311,588298,200297,475303,882292,061272,469263,122256,654253,384245,443241,109232,641220,639221,894216,149216,296176,450172,299169,073160,795150,574155,891154,133151,406143,43597,742111,400221,823241,741259,57486,850
   Common Stock
0
0
18,390
0
18,390
0
18,390
0
0
0
18,390
0
0
0
18,390
216,296
216,149
221,894
19,790
232,641
241,109
245,443
19,800
256,654
263,122
272,469
19,800
19,800
19,944
19,944
19,944
19,944
19,944
19,944
19,944
19,951
19,954
19,954
19,954
19,954
355,007
19,954
20,228
20,228
20,228
20,228
20,228
20,228
20,228
20,228
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
24,112
27,631
27,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00027,00027,63124,11222,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14420,22820,22820,22820,22820,22820,22820,22820,22819,954355,00719,95419,95419,95419,95419,95119,94419,94419,94419,94419,94419,94419,94419,80019,800272,469263,122256,65419,800245,443241,109232,64119,790221,894216,149216,29618,39000018,39000018,390018,390018,39000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-35,609
-40,552
-38,149
-40,984
-35,699
-30,255
-16,638
-12,569
-23,195
-11,888
-24,681
-23,773
-8,293
7,535
11,959
8,754
6,894
-6,782
12,567
43,344
58,378
49,118
50,254
65,590
69,764
87,200
60,846
109,486
59,015
53,657
1,924
516,754
17,319
25,519
20,584
169,000
595,000
892,000
1,164,000
1,341,000
2,009,000
1,641,000
1,144,000
1,541,000
1,394,000
1,315,000
0
0
001,315,0001,394,0001,541,0001,144,0001,641,0002,009,0001,341,0001,164,000892,000595,000169,00020,58425,51917,319516,7541,92453,65759,015109,48660,84687,20069,76465,59050,25449,11858,37843,34412,567-6,7826,8948,75411,9597,535-8,293-23,773-24,681-11,888-23,195-12,569-16,638-30,255-35,699-40,984-38,149-40,552-35,60900000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
494,610
494,610
494,610
483,763
494,610
494,610
494,610
4,025,886
13,543,973
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
0
0
0
0
0
0
00000013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,543,9734,025,886494,610494,610494,610483,763494,610494,610494,6100000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190,181
0
331,572
327,075
185,116
324,755
321,961
339,278
185,254
349,022
0
-50,167
183,348
178,291
220,287
220,287
220,287
220,287
220,287
220,287
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
483,763
494,610
494,610
494,609
4,025,886
13,543,973
13,545,000
13,543,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,543,000
13,542,000
13,543,000
15,219,000
14,601,000
14,601,00015,219,00013,543,00013,542,00013,543,00013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,543,00013,545,00013,543,9734,025,886494,609494,610494,610483,763494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610220,287220,287220,287220,287220,287220,287178,291183,348-50,1670349,022185,254339,278321,961324,755185,116327,075331,5720190,181000000000000000000000000000000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,609,000
Cost of Revenue-1,470,000
Gross Profit2,139,0002,139,000
 
Operating Income (+$)
Gross Profit2,139,000
Operating Expense-1,356,000
Operating Income783,000783,000
 
Operating Expense (+$)
Research Development117,000
Selling General Administrative478,000
Selling And Marketing Expenses754,000
Operating Expense1,356,0001,349,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-109,000
Net Interest Income-109,000
 
Pretax Income (+$)
Operating Income783,000
Net Interest Income-109,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)674,000892,000
EBIT - interestExpense = 0
673,000
513,000
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0674,000
Earnings Before Interest and Taxes (EBITDA)783,000
 
After tax Income (+$)
Income Before Tax674,000
Tax Provision-160,000
Net Income From Continuing Ops514,000514,000
Net Income513,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,826,000
Total Other Income/Expenses Net-109,000109,000
 

Technical Analysis of Vitrolife
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vitrolife. The general trend of Vitrolife is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vitrolife's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vitrolife Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vitrolife AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 145.43 < 146.00 < 148.90.

The bearish price targets are: 134.40 > 122.21.

Know someone who trades $VITR? Share this with them.πŸ‘‡

Vitrolife AB Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vitrolife AB. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vitrolife AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vitrolife AB. The current macd is -3.61778137.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vitrolife price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vitrolife. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vitrolife price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vitrolife AB Daily Moving Average Convergence/Divergence (MACD) ChartVitrolife AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vitrolife AB. The current adx is 18.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vitrolife shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vitrolife AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vitrolife AB. The current sar is 134.40.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vitrolife AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vitrolife AB. The current rsi is 46.46. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Vitrolife AB Daily Relative Strength Index (RSI) ChartVitrolife AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vitrolife AB. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vitrolife price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vitrolife AB Daily Stochastic Oscillator ChartVitrolife AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vitrolife AB. The current cci is -27.2450734.

Vitrolife AB Daily Commodity Channel Index (CCI) ChartVitrolife AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vitrolife AB. The current cmo is 2.50418216.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vitrolife AB Daily Chande Momentum Oscillator (CMO) ChartVitrolife AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vitrolife AB. The current willr is -44.30379747.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vitrolife is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vitrolife AB Daily Williams %R ChartVitrolife AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Vitrolife AB.

Vitrolife AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vitrolife AB. The current atr is 4.36720104.

Vitrolife AB Daily Average True Range (ATR) ChartVitrolife AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vitrolife AB. The current obv is -1,307,394.

Vitrolife AB Daily On-Balance Volume (OBV) ChartVitrolife AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vitrolife AB. The current mfi is 20.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vitrolife AB Daily Money Flow Index (MFI) ChartVitrolife AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vitrolife AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Vitrolife AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.457
Ma 20Greater thanMa 50144.245
Ma 50Greater thanMa 100150.352
Ma 100Greater thanMa 200165.112
OpenGreater thanClose141.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vitrolife with someone you think should read this too:
  • Are you bullish or bearish on Vitrolife? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vitrolife? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.


Comments

How you think about this?

Leave a comment

Stay informed about Vitrolife AB.

Receive notifications about Vitrolife AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.